Soto, L., Sabugo, F., Catalan, D., Wurmann, P., Cermenatti, T., Gatica, H., . . . Cuchacovich, M. (2011). The presence of anti-citrullinated protein antibodies (acpa) does not affect the clinical response to adalimumab in a group of ra patients with the tumor necrosis factor (tnf) alpha-308 g/g promoter polymorphism.
Citação norma ChicagoSoto, Lilian, et al. The Presence of Anti-citrullinated Protein Antibodies (acpa) Does Not Affect the Clinical Response to Adalimumab in a Group of Ra Patients With the Tumor Necrosis Factor (tnf) Alpha-308 G/g Promoter Polymorphism. 2011.
Citação norma MLASoto, Lilian, et al. The Presence of Anti-citrullinated Protein Antibodies (acpa) Does Not Affect the Clinical Response to Adalimumab in a Group of Ra Patients With the Tumor Necrosis Factor (tnf) Alpha-308 G/g Promoter Polymorphism. 2011.